Extensive Therapeutic Knowledge & Experience
Indero supports pharmacovigilance for dermatology, rheumatology, and a wide range of other therapeutic areas.
Pharmacovigilance services for any drug, biologic and medical device in any indication.
Indero’s pharmacovigilance team assesses and manages drug safety to ensure regulatory compliance and mitigate risks associated with adverse events. Here’s an overview of our key pharmacovigilance services:
Indero supports pharmacovigilance for dermatology, rheumatology, and a wide range of other therapeutic areas.
When sites report SAEs or SUSARs to Indero’s pharmacovigilance unit, we respond in a timely, coordinated manner to ensure an up-to-date, compliant safety database.
Indero has over 25 years of experience in meeting sponsor expectations with high quality, compliant drug safety data. Tell us about your pharmacovigilance needs today.
Scientific discipline. Operational efficiency. Clinical development expertise. Our pharmacovigilance services provide the rigorous foundation, quality data, and expertise clinical trials need to ensure effective execution and on-time delivery.
“The expertise and motivation Indero brought to the table were pivotal to our success. From the initial synopsis development to the final stages of study conduct, the synergy between our teams was palpable and was underpinned by Indero’s strong relationships with sites, investigators, and KOLs.”
Senior Vice President,
Clinical Development
Wherever
You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
3530 Saint-Laurent Boulevard
Suite 300
Montreal, QC, H2X 2V1, Canada
© 2025 Indero. All Rights Reserved. Privacy Policy. Designed and developed by Altitude Marketing.
We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Innovaderm will continue to operate as a CRU for dermatology studies.
Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
